These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12881316)

  • 1. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Remstein ED; Offord JR; Larson DR; Plevak MF; Melton LJ
    Blood; 2003 Nov; 102(10):3759-64. PubMed ID: 12881316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    Semin Oncol; 2003 Apr; 30(2):169-71. PubMed ID: 12720130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV; Therneau TM; Larson DR; Plevak MF; Melton LJ
    Clin Lymphoma; 2005 Mar; 5(4):257-60. PubMed ID: 15794860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra E; Cesana C; Klersy C; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Barbarano L; Lazzarino M;
    Semin Oncol; 2003 Apr; 30(2):172-7. PubMed ID: 12720131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathies of undetermined significance: a review.
    Kyle RA; Rajkumar SV
    Immunol Rev; 2003 Aug; 194():112-39. PubMed ID: 12846812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
    Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
    Kyle RA; Benson J; Larson D; Therneau T; Dispenzieri A; Melton Iii LJ; Rajkumar SV
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):17-8. PubMed ID: 19362962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
    Varettoni M; Zibellini S; Boveri E; Klersy C; Candido C; Rattotti S; Ferretti VV; Defrancesco I; Mangiacavalli S; Nizzoli ME; Flospergher E; Zerbi C; Bergamini F; Benvenuti P; Brociner M; Merati G; Paulli M; Arcaini L
    Br J Haematol; 2019 Nov; 187(4):441-446. PubMed ID: 31276195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
    Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ].
    Decaux O; Cazalets-Lacoste C; Cador-Rousseau B; Laurat E; Sebillot M; Bracq J; Jego P; Leblay R; Grosbois B
    Rev Med Interne; 2002 Sep; 23(9):751-8. PubMed ID: 12378828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
    Higgins L; Nasr SH; Said SM; Kapoor P; Dingli D; King RL; Rajkumar SV; Kyle RA; Kourelis T; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Ansell SM; Gonsalves WI; Thompson CA; Fervenza FC; Zand L; Hwa YL; Jevremovic D; Shi M; Leung N
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1037-1046. PubMed ID: 29848505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia.
    Kyle RA; Therneau TM; Dispenzieri A; Kumar S; Benson JT; Larson DR; Melton LJ; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):184-6. PubMed ID: 23490989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism.
    Jalali S; Shi J; Ahsan N; Wellik L; Serres M; Buko A; Paludo J; Kim H; Tang X; Yang ZZ; Novak A; Kyle R; Ansell S
    Redox Biol; 2021 May; 41():101927. PubMed ID: 33690107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
    N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.